+ Translate

The effects of genetic and phenotypic production potential on response to recombinant bovine somatotropin

, : The effects of genetic and phenotypic production potential on response to recombinant bovine somatotropin. Journal of Dairy Science 75(3): 878-884

Evidence was sought for an interaction between both phenotypic and genetic production potential and response of milk production to administration of bST in three trials of 38, 43, and 35 cows. In each trial, bST was administered in doses of 0, 10.3, 20.6, and, in trial 1 only, 41.2 mg/d for 38 wk from wk 4 of lactation. Data were analyzed for each experiment separately and combined across experiments. Analyses included separate regressions for treated and untreated animals for milk production during the production period on pretreatment production and estimated breeding value for milk production. Breeding value was estimated as the sire's estimated transmitting ability plus one-half of the maternal grandsire's estimated transmitting ability. With the exception of regression on estimated breeding value in trial 1 and in combined data, differences between treated and untreated animals in the regression of milk production on pretreatment milk production or on estimates of breeding value were not statistically significant. However, regressions on pretreatment production were substantially lower for treated than for untreated animals in each of the three trials. Regressions on breeding value estimated from sire and maternal grandsire estimated transmitting abilities were substantially, but not significantly, lower for untreated than for treated animals in all three trials. The results suggest that cows with high production potential for nongenetic reasons may show diminished response to bST, whereas cows with genetically high production potential show enhanced response. However, borderline statistical significance argues for considerable further examination before drawing firm conclusions.

Accession: 002249189

PMID: 1569278

DOI: 10.3168/jds.S0022-0302(92)77828-X

Download PDF Full Text: The effects of genetic and phenotypic production potential on response to recombinant bovine somatotropin

Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:

Related references

Leitch, H.W.; Burnside, E.B.; McBride, B.W.; Macleod, G.K., 1986: Administration of recombinant bovine somatotropin to Holstein cows: genetic and phenotypic effects. 34 multiparous and primiparous Holstein-Friesian cows were, given 0, 12.5, 25 or 50 mg recombinant bovine somatotropin daily for 266 days. Milk yield was increased 18.5, 20.0 and 21.4% by 12.5, 25 and 50 mg somatotropin resp. (P<0.05); fat yiel...

Nytes, A.J.; Combs, D.K.; Shook, G.E.; Shaver, R.D.; Cleale, R.M., 1990: Response to recombinant bovine somatotropin in dairy cows with different genetic merit for milk production. 39 multiparous cows from 2 genetic groups (mated for 20 yr to bulls of high or low transmitting ability for milk yield) were given 0, 10.3, 20.6 or 30.9 mg somatotropin daily from the 14th wk after parturition for 30 wk. The cow genetic indices ra...

Leitch, H.W.; Burnside, E.B.; McBride, B.W., 1990: Treatment of dairy cows with recombinant bovine somatotropin: genetic and phenotypic aspects. 34 multiparous and primiparous Holstein cows (representing a range of phenotypic and genetic production potentials) were given daily injections of 0 (controls), 12.5, 25.0 or 50.0 mg recombinant bovine somatotropin for 266 days beginning on day 24...

Burton J.H., 1987: Genetic and phenotypic affects of administration of recombinant bovine somatotropin to holstein cows. Journal of Dairy Scienceppl. 1: 128

Yoo, G.; Lee, S.; Park, G.-Jun; Choi, S.-Min; Eme, O.-Okorie; Kim, Y.-Chul; Kim, K.-Woong; Kang, Y.-Jin; Bai, S., C., 2007: Effects of dietary recombinant bovine somatotropin levels on growth, plasma recombinant bovine somatotropin concentrations, and body composition of juvenile Korean rockfish, Sebastes schlegeli. This experiment was conducted to study the effects of the graded recombinant bovine somatotropin (rBST) levels on growth, plasma rBST concentrations, and body composition of Korean rockfish, Sebastes schlegeli, and to estimate the optimum oral do...

Dalke B.S.; Garber M.J.; Roeder R.A.; Kasser T.R.; Comstock C.J.; Reeve N.A.; Schelling G.T., 1991: Dose response effects of recombinant bovine somatotropin rbst on serum somatotropin and insulin like growth factor 1 levels in steers. Journal of Animal Science 69(SUPPL 1): 299

Eisenbeisz, W.A.; Casper, D.P.; Schingoethe, D.J.; Ludens, F.C.; Shaver, R.D., 1988: Lactational evaluation of recombinant bovine somatotropin with corn and barley diets: response to somatotropin. Injections of recombinant bovine somatotropin at 10.3, 20.6 or 30.9 mg/day in wk 15-44 of lactation increased av. daily DM intake (21.4, 22.3 and 23.5 vs. 21.0 kg) and milk yield (30.3, 31.5 and 30.0 vs. 23.7 kg); the response was similar for cows...

Aaron, D.K.; Ely, D.G.; Deweese, W.P.; Fink, E.; Garrett, J.L., 1999: Does level of milk production affect response of lactating ewes to recombinant bovine somatotropin?. Journal of Animal Science 77(SUPPL 1): 21-22

Jones W.P.; Hansen L.B.; Chester Jones H.; Marx G.D.; Donker J.D.; Otterby D.E.; Hansen W.P.; Eggert R.G., 1991: Response of cows from divergent genetic lines for milk yield and body size to recombinant bovine somatotropin. Journal of Dairy Science 74(SUPPL 1): 263

Franson, S.E.; Cole, W.J.; Hoffman, R.G.; Meserole, V.K.; Sprick, D.M.; Madsen, K.S.; Hartnell, G.F.; Bauman, D.E., 1989: Response of cows throughout lactation to sometribove, recombinant methionly bovine somatotropin, in a prolonged release system - a dose titration study. Part I. Production response. Data pooled across 4 sites for 252 days of treatment indicated that primiparous cows treated with sometribove increased (P<0.05) 3.5% FCM by 3.0, 3.7 and 5.5 kg/day (12, 15 and 23%) over controls for 250, 500 and 750 mg treatment groups resp.;...